Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.07
+0.25 (3.67%)
May 29, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Reiterates $10 | Buy | Reiterates | $10 | +41.44% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 | Buy | Maintains | $25 | +253.61% | May 5, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $20 | Buy | Maintains | $20 | +182.89% | Apr 23, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $21 → $23 | Buy | Reiterates | $21 → $23 | +225.32% | Apr 6, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 1, 2026 |